In vitro Models of the Blood-Brain Barrier: Tools in Translational Medicine

被引:49
作者
Williams-Medina, Alberto [1 ,2 ]
Deblock, Michael [3 ]
Janigro, Damir [1 ,2 ]
机构
[1] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA
[2] Flocel Inc, Cleveland, OH 44103 USA
[3] Cleveland Clin Fdn, Dept Biomed Engn, Cleveland, OH USA
来源
FRONTIERS IN MEDICAL TECHNOLOGY | 2021年 / 2卷
关键词
in vitro; translational medicine; CNS drug delivery; Alzheimer ' s disease; COVID-19; microvesicles; multiple sclerosis; graphene; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS; SHEAR-STRESS; ELECTRICAL-RESISTANCE; ANTIEPILEPTIC DRUGS; STATUS EPILEPTICUS; P-GLYCOPROTEIN; P450; ENZYMES; NITRIC-OXIDE; HEAD TRAUMA;
D O I
10.3389/fmedt.2020.623950
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Medical progress has historically depended on scientific discoveries. Until recently, science was driven by technological advancements that, once translated to the clinic, fostered new treatments and interventions. More recently, technology-driven medical progress has often outpaced laboratory research. For example, intravascular devices, pacemakers for the heart and brain, spinal cord stimulators, and surgical robots are used routinely to treat a variety of diseases. The rapid expansion of science into ever more advanced molecular and genetic mechanisms of disease has often distanced laboratory-based research from day-to-day clinical realities that remain based on evidence and outcomes. A recognized reason for this hiatus is the lack of laboratory tools that recapitulate the clinical reality faced by physicians and surgeons. To overcome this, the NIH and FDA have in the recent past joined forces to support the development of a '' human-on-a-chip '' that will allow research scientists to performexperiments on a realistic replica when testing the effectiveness of novel experimental therapies. The development of a '' human-on-a-chip '' rests on the capacity to grow in vitro various organs-on-a-chip, connected with appropriate vascular supplies and nerves, and our ability to measure and perform experiments on these virtually invisible organs. One of the tissue structures to be scaled down on a chip is the human blood-brain barrier. This review gives a historical perspective on in vitro models of the BBB and summarizes the most recent 3D models that attempt to fill the gap between research modeling and patient care. We also present a summary of how these in vitro models of the BBB can be applied to study human brain diseases and their treatments. We have chosen NeuroAIDS, COVID-19, multiple sclerosis, and Alzheimer ' s disease as examples of in vitro model application to neurological disorders. Major insight pertaining to these illnesses as a consequence of more profound understanding of the BBB can reveal new avenues for the development of diagnostics, more efficient therapies, and definitive clarity of disease etiology and pathological progression.
引用
收藏
页数:20
相关论文
共 156 条
  • [1] ABBOTT NJ, 1992, J CELL SCI, V103, P23
  • [2] Microengineered human blood-brain barrier platform for understanding nanoparticle transport mechanisms
    Ahn, Song Ih
    Sei, Yoshitaka J.
    Park, Hyun-Ji
    Kim, Jinhwan
    Ryu, Yujung
    Choi, Jeongmoon J.
    Sung, Hak-Joon
    MacDonald, Tobey J.
    Levey, Allan, I
    Kim, YongTae
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [3] Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke
    Al Saiegh, Fadi
    Ghosh, Ritam
    Leibold, Adam
    Avery, Michael B.
    Schmidt, Richard F.
    Theofanis, Thana
    Mouchtouris, Nikolaos
    Philipp, Lucas
    Peiper, Stephen C.
    Wang, Zi-Xuan
    Rincon, Fred
    Tjoumakaris, Stavropoula, I
    Jabbour, Pascal
    Rosenwasser, Robert H.
    Gooch, M. Reid
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2020, 91 (08) : 846 - 848
  • [4] Novel Central Nervous System (CNS)-Targeting Protease Inhibitors for Drug-Resistant HIV Infection and HIV-Associated CNS Complications
    Amano, Masayuki
    Salcedo-Gomez, Pedro Miguel
    Yedidi, Ravikiran S.
    Zhao, Rui
    Hayashi, Hironori
    Hasegawa, Kazuya
    Nakamura, Tomofumi
    Martyr, Cuthbert D.
    Ghosh, Arun K.
    Mitsuya, Hiroaki
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (07)
  • [5] SEIZURES AFTER HEAD TRAUMA - A POPULATION STUDY
    ANNEGERS, JF
    GRABOW, JD
    GROOVER, RV
    LAWS, ER
    ELVEBACK, LR
    KURLAND, LT
    [J]. NEUROLOGY, 1980, 30 (07) : 683 - 689
  • [6] THE INCIDENCE, CAUSES, AND SECULAR TRENDS OF HEAD TRAUMA IN OLMSTED-COUNTY, MINNESOTA, 1935-1974
    ANNEGERS, JF
    GRABOW, JD
    KURLAND, LT
    LAWS, ER
    [J]. NEUROLOGY, 1980, 30 (09) : 912 - 919
  • [7] Appelt-Menzel Antje, 2020, Curr Protoc Stem Cell Biol, V55, pe122, DOI 10.1002/cpsc.122
  • [8] Shear stress and the endothelium
    Ballermann, BJ
    Dardik, A
    Eng, E
    Liu, AL
    [J]. KIDNEY INTERNATIONAL, 1998, 54 : S100 - S108
  • [9] Evidence that the species barrier of human immunodeficiency virus-1 does not extend to uptake by the blood-brain barrier: Comparison of mouse and human brain microvessels
    Banks, WA
    Kumar, VB
    Franko, MW
    Bess, JW
    Arthur, LO
    [J]. LIFE SCIENCES, 2005, 77 (19) : 2361 - 2368
  • [10] The blood-brain barrier in neuroAIDS
    Banks, Wiliam A.
    Ercal, Nuran
    Otamis Price, Tulin
    [J]. CURRENT HIV RESEARCH, 2006, 4 (03) : 259 - 266